Crucell, NV
Dutch biotech reports increased Q3 revenues
Published in Lab Business Week, November 14th, 2004
Crucell reports revenues of EUR 4.1 million (US$5.1 million) for the third quarter 2004, which represents a significant increase over the EUR 1.2 million (US$1.4 million) in revenues the company reported for the same quarter last year.
"We have continued to attract new licensees and partners at a record rate, while making significant advances in moving our own portfolio of products towards clinical development," said Ronald Brus, MD, Crucell's chief executive officer.
Brus said the company's flu vaccine partnership with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-11-14)
More Articles from Lab Business Week
- Biopure Corporation
Pharma firm appoints Jay B. Pieper, Kenneth Ouriel to its boards - Business & Finance
D&K Healthcare expects Q1 loss, completes acquisition of PBI - Business Update
Amgen's profit surge on strong drug sales - Cell Genesys, Inc.
Cancer vaccine maker reports loss of $0.54 per share - CoAxia, Inc.
Device company receives $17.6M in series B funding - Curis, Inc.
Regeneration-focused company to raise $13.2M in registered direct offering - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
